Analyst Ryan MacDonald of Needham reiterated a Buy rating on Phreesia (PHR – Research Report), retaining the price target of $29.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ryan MacDonald has given his Buy rating due to a combination of factors including Phreesia’s strong financial performance in the first quarter of 2026. The company’s revenue aligned with market expectations when excluding a one-time benefit, and it demonstrated significant improvement in adjusted EBITDA margins, particularly through better cost management in sales and general administrative expenses.
Additionally, Phreesia’s management has reported no adverse effects on their business pipeline from broader economic conditions, which suggests resilience and stability. This, combined with a conservative outlook for the fiscal year 2026 and a history of effective execution, supports the view that there is further upside potential in Phreesia’s financial performance, justifying the Buy rating.
Based on the recent corporate insider activity of 163 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PHR in relation to earlier this year.